En español
NIDA

Director's Perspective

Seek-Test-Treat-Retain To Stop the Spread of HIV

NIDA Director Nora Volkow

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

The Present and Promise of mHealth

NIDA Director Nora Volkow

NIDA researchers have developed a computer program that motivates and encourages treatment-seeking when an individual is in a primary care physician’s waiting room. Users of the program, called Video Doctor, enter information on a portable device and receive feedback about health risks related to their drug abuse, along with advice, immediately prior to seeing their physician.

Research Focuses on Groups With High Smoking Rates

NIDA Director Nora Volkow
Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

Substance Abuse Among Older Adults

NIDA Director Nora Volkow

Understanding and responding to drug abuse among America’s aging population becomes more urgent as a growing percentage of baby boomers enter the over-50 age bracket.

NIDA's Drug Abuse Research Advances Science as a Whole

NIDA Director Nora Volkow

NIDA Director Dr. Nora D. Volkow summarizes instances where discoveries with broad implications for human health arose from scientists seeking answers to addiction problems.

NIDA's Funding Priorities To Remain Constant

NIDA Director Nora Volkow

Reports on NIDA’s research priorities—drug abuse and addiction prevention, treatment, and HIV/AIDS—which will remain consistent during these challenging budget times.

Genes and Smoking

NIDA Director Nora Volkow

Reports on the research underway to identify gene variations associated with nicotine addiction and the interaction of genetic makeup, experiences, and surroundings to addiction.

NIDA Will Contribute to Obesity Research

NIDA Director Nora Volkow

Describes an NIH-wide obesity task force and research plan and explores some of the links between addiction and compulsive eating.

Epigenetics: The Promise of a New Science

NIDA Director Nora Volkow

Discusses the role of epigenetics, the study of cellular mechanisms that control gene expression and its impacts on health and behavior, in addiction research.

Pages

Subscribe to Director's Perspective